P. Walichiewicz, J. Piecuch, B. Białas, W. Orkisz, M. Fijałkowski, K. Slosarek, L. Miszczyk
{"title":"Endovascular gamma irradiation of the iliac arteries: 1-year results from a clinical safety and feasibility study.","authors":"P. Walichiewicz, J. Piecuch, B. Białas, W. Orkisz, M. Fijałkowski, K. Slosarek, L. Miszczyk","doi":"10.1583/1545-1550(2003)010<0573:EGIOTI>2.0.CO;2","DOIUrl":null,"url":null,"abstract":"PURPOSE\nTo estimate safety and feasibility of vascular brachytherapy in iliac arteries.\n\n\nMETHODS\nFourteen patients (11 men; mean age 56.7+/-9.9 years, range 44-81) with occlusive disease in 15 iliac arteries (7 external, 8 common) were treated with balloon dilation followed by irradiation from an iridium 192 source (15 Gy at 3 mm from the inner surface of the artery wall) applied with a PARIS centering catheter and bilateral 10-mm margins. Patients receiving stents for suboptimal angioplasty were prescribed a 6-month course of antiplatelet treatment with ticlopidine. Angiography was routinely scheduled for 6 months after intervention.\n\n\nRESULTS\nThere were no complications of the angioplasty procedure or EVBT treatment; 7 patients received stents for dissection or residual stenosis. Mean follow-up was 12.4+/-6.0 months. At 6-month angiography, 1 (6.7%) restenosis in a common iliac artery stent was found. Another patient with a common iliac artery stent developed transient lower limb ischemia at 4 months, probably due to temporary suspension of antiplatelet treatment and distal disease.\n\n\nCONCLUSIONS\nBrachytherapy in the iliac arteries appears to be feasible and safe; longer follow-up in more patients is needed to determine its clinical utility in the prevention of restenosis.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"8 1","pages":"573-6"},"PeriodicalIF":0.0000,"publicationDate":"2003-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"血管与腔内血管外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1583/1545-1550(2003)010<0573:EGIOTI>2.0.CO;2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
PURPOSE
To estimate safety and feasibility of vascular brachytherapy in iliac arteries.
METHODS
Fourteen patients (11 men; mean age 56.7+/-9.9 years, range 44-81) with occlusive disease in 15 iliac arteries (7 external, 8 common) were treated with balloon dilation followed by irradiation from an iridium 192 source (15 Gy at 3 mm from the inner surface of the artery wall) applied with a PARIS centering catheter and bilateral 10-mm margins. Patients receiving stents for suboptimal angioplasty were prescribed a 6-month course of antiplatelet treatment with ticlopidine. Angiography was routinely scheduled for 6 months after intervention.
RESULTS
There were no complications of the angioplasty procedure or EVBT treatment; 7 patients received stents for dissection or residual stenosis. Mean follow-up was 12.4+/-6.0 months. At 6-month angiography, 1 (6.7%) restenosis in a common iliac artery stent was found. Another patient with a common iliac artery stent developed transient lower limb ischemia at 4 months, probably due to temporary suspension of antiplatelet treatment and distal disease.
CONCLUSIONS
Brachytherapy in the iliac arteries appears to be feasible and safe; longer follow-up in more patients is needed to determine its clinical utility in the prevention of restenosis.